Clinical Trial Update: A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of combining tivozanib with capecitabine in adults with advanced solid tumors, including locally advanced or metastatic br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Tivozanib (tivozanib)

Snippet

Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Advanced Solid Tumors, Locally Advanced or Metastatic Breast or Colorectal Cancer | Phase 1 | Status: COMPLETED